Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor
US7226757B2 · kind B2 · utility
0Cited by
9References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 24, 2006 |
| Grant date | Jun 5, 2007 |
| Priority date | — |
| Expiry date | Jan 24, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/8114
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions are described that are suitable for formulating TFPI. Solubilizers and stabilizers facilitate the preparation of pharmaceutically acceptable compositions of TFPI at various concentrations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.